Join us

Oncoinvent presents a unique opportunity to join an expanding pharmaceutical start-up with both R&D and production established in-house which enables both hands-on lab work as well as working with external partners.

The company has solid owners and is in a clinical phase with its lead product (Radspherin®) which is produced in Nydalen.

The candidates should be looking for the energy in a start up with the ambition to make a difference. Successful candidates should be flexible, team-oriented yet able to work independently, and be analytical and results oriented.

If you would like to send us an open application, please send your application and résumé to


QC technician

Oncoinvent AS is looking for a QC technician to strengthen the QC team at the company’s manufacturing facility in Oslo. The QC team at Oncoinvent is tasked with the development and GMP compliant QC of radiopharmaceuticals.

Exciting position as a QC technician in a dynamic company

Oncoinvent is a privately held Norwegian company based in Nydalen, Oslo. The company is committed to developing novel, innovative products to provide better treatment options for cancer patients.

The Oncoinvent team consists of 44 employees and the company anticipates further growth. Oncoinvent holds a state-of-the-art manufacturing facility to produce drug products intended for use in pre-clinical and clinical trials. Clinical trials for Oncoinvent’s lead product, Radspherin® are ongoing. For further details on Oncoinvent see

The facility holds a GMP certificate from the Norwegian Medical Agency. The approval provides the company with the necessary flexibility and capacity for manufacturing clinical trial material for both patients and trial sites, as well as developing the company further.

The company’s lead product candidate Radspherin® is a novel alpha-emitting radioactive microsphere suspension designed for treatment of micro-metastatic cancers in body cavities. The radium-224 based therapeutic, Radspherin® has shown strong and consistent anticancer activity at doses being essentially non-toxic in preclinical studies. It is anticipated that the product can potentially treat several forms of micro-metastatic cancer.

The development programs of the pipeline of the company include targeted radionuclide therapy for treatment of various solid cancers. The main focus of discovery is on alpha-emitting radionuclides for treatment by regional administration of the drug in body compartments with disseminated solid tumours.

Oncoinvent AS is looking for a QC technician to strengthen the QC team at the company’s manufacturing facility in Oslo. The QC team at Oncoinvent is tasked with the development and GMP compliant QC of radiopharmaceuticals. The position is an exciting opportunity to work in an innovative and dynamic start-up company and participate in the development of novel pharmaceuticals.

The successful candidate will, together with the QC team and other Oncoinvent staff, drive the manufacture and development of Radspherin® for pre-clinical and early-phase clinical trials.

This position requires work with radioactive materials. A successful candidate is therefore expected to comply with radiation protection and other health and safety procedures during laboratory- and QC scale experiments, and GMP QC activities.

  Key responsibilities:
  • Routine testing of raw materials, intermediates and finished product
  • Perform Environmental Monitoring, trending and reporting
  • Resolve, in collaboration with the QC, QA and production team, out-of-specification or unexpected results and analytical and product problems
  • Record and report results of analysis in accordance with prescribed lab procedures and systems
  • Help with maintaining the calibration and qualification status of Oncoinvent’s QC facility, equipment and instruments
  • Writing of SOPs and other instructional documents
  • Ordering of laboratory supplies and equipment
  • Handling of incoming goods.
  • Housekeeping including handling of radioactive and non-active waste.
  • The position requires work with radioactive materials. It is therefore important to comply with radiation protection and other health and safety procedures during laboratory experiments.
Qualifications and experience:
The holder of this position should have the following documented qualifications and experience:
  • Bachelor, high school degree in science- or a technical relevant discipline.
  • Working knowledge in Norwegian and English.
  • 1-3 years practical, hands-on experience in the QC of pharmaceuticals.
The following experience is desirable:
  • Familiarity with GMP regulations
  • A successful candidate will have to be able to work well in a multidisciplinary team while being able to plan and perform practical work independently and communicating clearly and effectively.
  • The QC of pharmaceuticals is highly regulated, and a successful candidate will be expected to show attention to detail with respect to planning and documentation of practical work.
The holder of this position will be based at Oncoinvent AS facilities, Gullhaugveien 7, 0484 Oslo. The position will report to the Head of QC.

Application deadline:
We are reviewing the applications on a rolling basis.

Please submit your application with a motivational letter stating “why Oncoinvent” and what you can contribute to the position as well as an updated CV. Application without this will not be reviewed further.


Bjørn Fuglaas CEO Life Science Partners AS +47-90775752


Jan Alan Alfheim

Chief Executive Officer

+47 464 40 045

Jan A. Alfheim is a business executive with over thirty years’ experience bringing product ideas and technology to the chemical and pharmaceutical markets, from product concept inception through discovery and development phases to final marketing campaign and launch.

With experience in research, project management, business development & partnering, company start-ups, and product launches, Alfheim comes from Nordic Nanovector ASA where he was Chief Executive Officer from 2011 until 2014 and Chief Operating Officer from 2014 to 2016. Prior to working at Nordic Nanovector, he has held various senior roles including Chief Business Officer at Clavis Pharma, President of StemPath Inc, Director of Business Development at Neurochem Inc and Project Director at Nycomed Imaging. Mr. Alfheim holds a MSc from Concordia University and a MBA from McGill University.